icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
San Francisco
November 2018
Back grey_arrow_rt.gif
 
 
 
Effectiveness of Sofosbuvir/Velpatasvir for 12 Weeks in HCV Genotype 3 Patients with Compensated Cirrhosis in Clinical Practice Cohorts from Around the World
 
 
  Reported by Jules Levin
AASLD 2018 Nov 9-12 Boston

1114181

1114182

1114183

1114184